Chap 13 and 14 Flashcards
Antiinfective agents currently approved for administration as inhaled aerosols
Pentamidine isethonate (NebuPent), Ribavirin (Virazole), Tobramycin (TOBI), Aztreonam (Cayston), and zanamivir (Relenza)
Pentamidine is used to
prevent and treat Pneumocystic pneumonia (PCP) in patients with acquired immunodeficiency syndrom (AIDS),
Ribavirin is used to
treat respiratory synctial virus (RSV). A single or monoclonal antibody preparation, Palivizumab (Synagis) offers prophylaxis and treatment for RSV infection
Inhaled tobramycin and aztreonam are available for the management of
Pseudomonas aeruginosa infection in pts with CF
Zanamivir is an inhaled antiviral agent used to treat
influenza
Pentamidine by inhalation is indicated for the prevention of
PCP in high risk immunodeficiency virus (HIV)- infected pts who have a history of one or more episodes of PCP or a peripheral CD4 (T4 helper cell), lymphocyte count of 200/mm or less
Aerosolized ribavirin is indicated for the
treatment of hospitalized infants with RSV
Aerosolized tobramycin is indicated for the
management(control) of chronic P. aeruginosa infection in CF
Aerosolized Aztreonam is indicated to improve
pulmonary symptoms in CF pts with P. aeruginosa infection
Inhaled zanamivir is indicated for the
Treatment of uncomplicated acute illness caused by the influenza in adults and children age 7 years and older who have been symptomatic for no more than 2 days. It may also be used prophylactically in children 5 years and older against the influenza virus
Pentamidine (NebuPent) is a what agent
antiprotozoal agent that is active agains Pneumocystis carinii that causative organism for Pneumocystic jiroveci pneumonia (PJP)
Pentamidine (NebuPent) can be given either
parenterally (IV/IM-distributes quickly to major organs) or as an inhaled aerosol, but it is not absorbed with oral administration
Aerosolized Pentamidine isethionate is approved for use as ___ prophylactic therapy in pts with AIDS to prevent PCP
Second line prophylactic therapy… With significant side effects and less efficacy than with the oral agent trimethoprimsulfamethoxazole (TMP-SMX).
Pentamidine side effects
local airway effects, such as cough, bronchospasm, and dyspnea, and a bad taste and systemic effects
Aerosolized pentamidine should be administered
with a neb capable of producing small particle sizes (MMD 1-2um) in Respirgard II neb flow rate of 5-7 L/min
Approved dose of aerosolized Pentamidine (NebuPent)
300mg given by inhalation once every 4 weeks, Supplied as a dry powder with 300mg in single vial, reconstituted with 6 ml of sterile water for injection. 6ml placed into nebulizer
Sterile water not saline
saline can cause precipitation
Where is Pentamidine excreted
75% in urine and 25% in feces over the months after administration
Pentamidine is not
Teratogenic, mutagenic, and carcinogenic potential is minimal
Pentamidine Environment precautions
One way valves and an expiratory filter
stop neb if pt takes mouthpiece out of mouth
MMD of 1-2 um to increase alveolar targeting
Screen pt for cough history
use of Bagonist
Administer aerosol in a negative pressure room with 6 air changes per hour
or consider using isolation booth/hood
Use barrier protection
Screen pts with HIV infection for TB
THESE TESTS ARE EXPENSIVE AND MEASURES ARE DIFFICULT
Ribavirin (virazole) is classified as a what drug
antiviral drug, it is active against RSV, influenza viruses (type A and B), and the herpes simplex virus. (possibly inefective)
Ribavirin (virazole) virostatic or virucidal?
Virostatic and inhibits DNA and RNA (viruses). synthetic nucleoside analag
Infection with RSV in children results in either
bronchiolitis or pneumonia (november to march, winter months)
Virus
can be defined as an obligated intracellular parasite, containing either DNA or RNA, that reproduces by synthesis of subunits within the host cell and causes disease as a consequence of this replication
Ribavirin dosage
given as a 20mg/ml solution, SPAG-2 Neb for 12 to 18 hours per day, for a minimum of 3 days and not more than 7. The drug is supplied as a 6g of powder in 100ml vial, reconstitued in sterile water for injection or inhalation
SPAG-2
Large volume, pneumatically powered nebulizer operating on a jet shearing principle, with baffling of aerosol particales and a drying chamber to reduce particle size further to a level of approx 1.3 um MMD
Residual solution in reservoir should be discarded before adding new and solution should be visually inspected
Mechanism of action by which ribavirin exerts its virostatic effect
is not completely understood
Ribavirin side effects (Pulmonary, cardio, Hema, Derma)
Pulmonary- Deterioration of pulmonary function and worsening of asthma or COPD, pneumothorax, apnea, and bacterial pneumonia
Cardiovascular- Cardiovascular instability= hypotension, cardiac arrest, and digitalis toxicity
Hematologic- Effects on blood cells
Dermatologic/topical- rash, eyelid erythema, and conjunctivitis
Ribavirin has potential for
mutagenic and carcinogenic effects based on in vitro and animal studies, drug has caused testicular lesions in rats, it is teratogenic or embryocidal in animal species
Palivisumab ( Synagis)
New drug class of therapeutic monoclonal antibodies -approved for the prevention and treatment of RSV in premature infants and infants with bronchopulmonary dysplasia (BPD)
Palivisumab (Synagis) Dosage and administration
Powder for injection is lyophilized or freeze-dried and is available at 50mg/ml or 100mg/ml. Recommended dose is 15mg/ml given IM once a month before the start of and throughout the RSV season
Palivisumab (synagis) mechanism of action
is a humanized monoclonal antibody produced by recombinant DNA techniques, directed against the F protein of RSV.
Most serious adverse reaction of Palivisumab (Synagis)
anaphylaxis (1 per 100,000 cases).. other less are fever, upper resp infection, otitis media, rhinitis, rash , pain, hernia, and coughing/wheezing
Nebulized tobramycin is used to manage
chronic Pseudomonas aeruginosa infection in pts with CF as an alternative to IV therapy
Side effects of tobramycin are
tinnitus and voice changes
Tobramycin dosage and administration
recommended for children 6 years of age or older.
300mg twice daily approx 12 hours apart and not less than 6 hours apart for 28 days consecutively, with the next 28 days off the drug. Cycle repeated. Keep in fridge temps 2-8C (36-46F)
Dont mix what with tobramycin
Dornase alfa or any other drug with tobramycin in the neb because of incompatibility with other drugs.. should be inhaled after other therapies
Tobi is a member of the
aminoglycoside family of antibiotics. Effective in treating gram negative infections and have a bactericidal effect, blocking protein synthesis in the bacteria and causing cellular death.
Aerosolized Aztreonam (Cayston) is used to improve
pseudomonas aeruginosa infection in pts with CF. Should be pretreated with a bronchodilator before.
Administration of Aztreonam (cayston)
given as IV solution, also inhaled, not indicated for pts younger than 7 years of age or those with B. cepacia. FEV1 greater than 25% or less than 75% predicted.
-Supplied in 28 day kit, each 2 ml single use flass vial contains 75 mg and mixed with 1ml sterile water
Aztreonam (cayston) nebulizer
Altera Neb system. 3 times a day for 28 days and 28 days off. Fridge, once open room temp 28 days
Mechanism of action of Aztreonam
displays in vitro activity agains gram negative erobic bacteria.
Cayston can cause
bronchospasm and decreased pts FEV1, pts should be screened for baseline pulmonary function
Zanamivir is available for administrationwith
a DPI to treat acute symptoms of influenza. inhibits viral neuraminidase (NA) -Diskhaler device. each blister contains 5mg of drug. Two inhalations, taken twice daily approx 12 hours apart for 5 days (5 day course of drug)
Zanamivir side effects
bronchospasm of lung deterioration, especially in preexisting airways disease and undertreatment of inapproprate treatment of nonviral bacterial resp infections
Zanamivir (Relenza) is an
antiviral agent approved for use in the treatment of uncomplicated influenza illness in adults and children older than 7 years of age during early onset (within the first 2 days) of infection.